Actively Recruiting
Observational Study to Evaluate Safety and Risk of Allergic Reactions from Sulbactam-durlobactam in Adults With Acinetobacter Baumannii-calcoaceticus Complex Infection
Led by Innoviva Specialty Therapeutics · Updated on 2026-06-24
100
Participants Needed
12
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This observational study aims to evaluate the safety of sulbactam-durlobactam and the risk of hypersensitivity reactions, including anaphylaxis, in adults with infections caused by the Acinetobacter baumannii-calcoaceticus complex. The study focuses on hospitalized participants who have a proven or strongly suspected ABC infection and are treated with sulbactam-durlobactam as part of their standard care. Participants will be observed for approximately 28 days to collect safety data related to treatment-emergent adverse events and hypersensitivity reactions. The study does not involve administering the treatment but monitors participants receiving sulbactam-durlobactam through routine clinical care. Data on liver function, vital signs, blood counts, and electrocardiogram QT measurements will also be collected at baseline and day 28. During the study, participants will be followed closely to record any adverse events and changes in clinical parameters. Researchers will measure the frequency, severity, and relatedness of adverse events and hypersensitivity reactions over the 28-day period. The study also tracks changes from baseline in various laboratory and vital sign measures to understand the safety profile of sulbactam-durlobactam in this patient group.
CONDITIONS
Brief Title
A Study to Assess the Safety and Risk of Hypersensitivity Reactions of Sulbactam-durlobactam in Adults With Acinetobacter Baumannii-calcoaceticus (ABC) Complex Infection
Research Team
R
Reddy Tummala ISTX Clinical Trials
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here